CSR

United Kingdom: Reopening for Business Essential Checklists for UK In-House Counsel

0
Businesses have to be adaptable when navigating the business and legal impact of the COVID-19 pandemic. Our Resilience, Recovery & Renewal model supports organizations...

Doing Business in China 2020

0
 The Doing Business in China guide provides an introduction to selected aspects relating to investment and business operations in the People’s Republic of China...

Ukraine: New rules of the game for renewables in Ukraine

0
On 31 July 2020, the President of Ukraine has signed the long-awaited law of Ukraine No. 810 "On Amendments to Certain Laws of Ukraine related to Improvements of the Terms of Support for Production of Electricity from Renewables Energy Sources" ("Law").Effective from 1 August 2020, the adjusted Feed-in-Tariff rates will apply to the renewable energy projects ("REP") in Ukraine. To see the Feed-in-Tariff ("FiT") rates please follow the link here.For the REPs commissioned before 30 June 2015, the FiT cap of EUR 24.56 KW/h will apply.WPPs with up to three wind turbines (irrespective of the capacity) are not any longer eligible for FiT.

TMT Talk Podcast Series – Latest Episode: Business Future Proofing – Compliance and Investigations

0
A tech-entwined world necessarily puts focus on technology companies and the opportunities that arise with them. TMT Talk, the Global TMT industry podcast, will help you navigate and prioritize via insights from top legal advisers in strategic technology markets. We'll go into the issues, how they affect businesses, society, and the way players deal with them.

EMEA: COVID-19 Life Sciences Survey (Updated)

0
As COVID-19 rapidly spreads to every corner of the globe and is officially declared a pandemic, governments across the world are adopting emergency measures to fight against this extraordinary situation. Ultimately, all these measures are aimed at protecting the health and wellbeing of citizens. However, on the healthcare and life sciences front in particular, such measures range from intervention powers to guarantee adequate supplies of treatment and medical equipment, to the relaxation of deadlines and regulatory requirements to simplify administrative procedures wherever possible, so that competent authorities, manufacturers and other actors can focus on urgent priorities related to the COVID-19 crisis.

The Slave-Free Business Certification Act: Bipartisanship Grows in Congress Around Aggressive Corporate Legal Obligations...

0
Overview On July 20, 2020, Republican Senator Josh Hawley of Missouri introduced the Slave-Free Business Certification Act (“the Act”).  If passed, the Act would require...

Hong Kong: Doing Business in Hong Kong 2020

0
Read publicationThis Doing Business Guide to Hong Kong summarizes the requirements for the establishment and maintenance of a Hong Kong company and a branch...

Africa: Private Equity Investors will Delve Deeper Into Africa to Search for Post-pandemic Opportunities

0
Wildu du Plessis, Partner and Head of Banking & Finance, and Marc Yudaken, Corporate/M&A Partner , in Baker McKenzie Johannesburg, discuss current trends in...

Italy: COVID-19 – European Commission, EMA and FDA agree on new priorities to strengthen...

0
On 18-19 June 2020, senior officials from the European Medicines Agency (EMA), the European Commission and the US Food and Drug Administration (FDA) held a meeting to review their ongoing joint initiatives, discuss strategic priorities for the coming years and identify areas where their collaboration could be strengthened.

Ukraine: State support for large investment projects

0
On 21 July 2020, Ukraine's parliament, the Verkhovna Rada of Ukraine, passed in the first reading a Draft Law No. 3760 "On State Support for Investment Projects with Significant Investments" ("Draft Law"). The Draft Law was proposed by the President of Ukraine as part of his investment promotion agenda and is aimed at enabling state support for major investments in Ukraine.
Send this to a friend